Background: Coping with chronic illness can be overwhelming for patients and caregivers, and may be inhibited by the denial mechanism, and therefore, denial represents a critical issue for health professionals. Assessing illness denial is far from easy, and brief tools suitable for medical settings are lacking. In this paper, the development of a short form of the Illness Denial Questionnaire (IDQ) for patients and caregivers is presented. Methods: In study 1, the IDQ was administered to 118 patients and 83 caregivers to examine the internal structure of denial; then the properties of the items (DIF, fit, and difficulty) were evaluated according to the Rasch model in order to select the best items for the Illness Denial Questionnaire-Short Form (IDQ-SF). Study 2 included 202 participants (113 patients and 89 caregivers). The internal structure of the IDQ-SF was tested via confirmatory factor analysis (CFA). Reliability and concurrent validity were also studied using the Anxiety and Depression Questionnaire-Reduced Form (AD-R). Results: The CFA showed a two-factor structure encompassing "Denial of negative emotions" and "Resistance to change". Results of the Rasch analyses led to the selection of 4 items for each dimension. The resulting IDQ-SF (8 items) showed a two-factor structure as well as good reliability and concurrent validity with AD-R. Conclusion: The IDQ-SF represents a valid tool for quickly evaluating the core of illness denial in patients and caregivers. This brief and easily administrable questionnaire allows health professionals to outline the presence and severity of illness denial in order to set individually tailored interventions.
Introduction
In recent decades, increasing attention has been paid in medical settings to clinically relevant psychological aspects given their well-known key role in influencing the medical care process in negative and positive ways. 1 Among the several psychological issues involved in medical settings, illness denial is one of the most controversial due to the scarce clarity in its definition and the consequent difficulties in its assessment. 2, 3 Denial was firstly introduced by Sigmund Freud as an unintentional defense mechanism that can be triggered by a distressful and threatening situation. 4, 5 Concerning medical settings, denial might be triggered by the onset of an illness and may consist of the negation of some aspects related to it. 6, 7 Indeed, denial can affect different areas, from the diagnosis itself up to subjective emotions and feelings, behavioral lifestyle changes, 8, 9 and modifications of interpersonal relationships. 10 Furthermore, illness denial can affect patients and their caregivers, who are frequently strongly involved in the process of physically and psychologically caring for their loved ones. 11 According to Freud, denial represents an initial phase in the process of achieving awareness of something that is repressed, without necessarily accepting it. 5 Thus, the cognitive-affective elaboration process of the illness might encompass fluctuant phases through different intensities of denial, which may finally result in awareness but not always in acceptance. 12 Even if denial can be considered a justified reaction in some phases of the illness, its persistency may be dysfunctional as it suppresses the adaptation process to reality. 13 An excessive use of denial may indicate that it would be harder to accept the reality of illness. 14 For example, dysfunctional denial may delay help-seeking requests for serious illness symptoms, thus postponing treatments, 15 or it could imply poor compliance with treatment or even involve an inadequate attitude of the caregiver in supporting the patient. 16, 17 Furthermore, denial needs to be distinguished from conscious, aware, and deliberate avoidance of the threatening condition. 18 It is important for health professionals to assess illness denial with reliable tools, but there is difficulty in retrieving specific and useful tools for this purposeas underlined in previous studies. 18 Indeed, the literature reports that semistructured interviews 19 or self-report questionnaires 20 have addressed only specific disorders and often have assessed something ambiguous instead of proper denial.
The Illness Denial Questionnaire (IDQ) 18 was created with the aim to assess denial in relation to illness, in patients and in caregivers and independently of the specific kind of illness or disturbance involved. The IDQ is a selfreport questionnaire consisting of 24 dichotomous items (true/false) that show good psychometric properties and a three-factor structure. The IDQ assesses three dimensions: "Denial of negative emotions," "Resistance to change," and "Conscious avoidance." "Denial of negative emotions" refers to the emotional reactivity, a subjective dimension, related to the individual's emotional life and to its regulation. This dimension encompasses different emotions and feelings, such as sadness, insecurity, worry, and anger. 21 "Resistance to change" concerns the behavioral efforts necessary to manage illness, and it is aimed at assessing the practical changes and modifications in one's lifestyle in order to adapt to a new situation (eg, medications, therapies). Such transformation and reorganization mainly concern individual behaviors and habits. 22 "Denial of negative emotions" and "Resistance to change" have been found to be the core components of denial. 18 Besides these, even a third dimension is present, namely "Conscious avoidance." This corresponds to a later and less severe critical stage of the illness elaboration process in which awareness is reached. At this point, acceptance of the illness's existence can begin. 23 Despite the validity of the conscious avoidance construct, it could be confounding to measure it together with denial since they are welldistinguished concepts: denial implies a lack of awareness and is a preliminary phase characterized by the removal of unpleasant material from consciousness; whereas in conscious avoidance, awareness is present but the individual voluntarily avoids facing a threatening situation. 23, 24 Furthermore, "Conscious avoidance" has proven to be independent and different from the core aspects of illness denialboth theoretically and psychometrically. 18 Illness denial represents a more severe clinical issue than conscious avoidance, and it is also more difficult to assess given the lack of awareness. Thus, denial represents a critical issue for clinical practice, and the present work is specifically aimed to assess it. Given this premise, the present study is focused on the central aspects of illness denial: "Denial of negative emotions" and "Resistance to change." Despite their interconnection, they concern two well-distinguished areas of the individual's life: emotional and behavioral.
Medical settings require short and reliable tools given their undoubted advantages: easy administration, suitable integration in longer routine assessment batteries, suitable administration to subjects with reduced attention ability, and rapid administration in medical wards such as waiting rooms. 25, 26 Brief tools can be used for monitoring the individual's progress over time, thus informing clinical decisions. The IDQ requires a time-consuming administration and a long scoring procedure, thus making it difficult for health professionals to immediately understand the actual denial condition of the patient/caregiver. To our knowledge, nowadays, brief tools specifically measuring illness denial are lacking. For these reasons, a short form of the IDQ is needed in order to conduct an efficient and valid assessment of illness denial. Furthermore, since denial affects patients and caregivers, a unique assessment tool suitable for both is desirable. This paper is aimed at developing and validating a brief version of the IDQ, which will be called Illness Denial Questionnaire-Short Form (IDQ-SF). In Study 1, the factor structure of the IDQ considering the two dimensions of "Denial of negative emotions" and "Resistance to change" was tested via confirmatory factor analysis (CFA).
Then, the properties of the items were evaluated with the Rasch model analysis 27 in order to select the items with the best psychometric properties for the IDQ-SF. In Study 2, the factor structure and psychometric properties of the IDQ-SF were investigated.
Study 1 Materials and methods

Participants
In line with the previous study, 18 
Instruments
The IDQ 18 was administered to participants who were asked to express in a dichotomous form (false=0; true=1) if their experience was represented by each of the 24 statements. The IDQ evaluates three dimensions: "Denial of negative of emotions" (7 items; eg, "This disorder/ disease frightens me"), "Resistance to change" (9 items; eg, "Nothing in my life will change on account of this disorder/disease"), and "Conscious avoidance" (8 items; eg, "I try not to pay any attention to my disorder/disease"). The first two dimensions were found to express the real form of denial, while the latter dimension of "Conscious avoidance" represented a more advanced stage of the illness elaboration process. 18 After recoding the reverse items, higher scores on the IDQ expressed higher levels of denial. A psychologist introduced the study. All participants gave informed consent to use their data in anonymous form. The ethical committee of the Maugeri Scientific Institute discussed and approved the study.
Statistical analyses
In the first part of Study 1, the IDQs factor structure was tested through CFA, and reliability and validity were evaluated. Only the two main factors of denial were considered: "Denial of negative emotions" and "Resistance to change." 18 The diagonally weighted least squares (DWLS) estimator was used 28 given its suitability for categorical data. The goodness-of-fit was evaluated considering chi square, the χ 2 /df ratio, the comparative fit index (CFI), 29 the Tucker-Lewis index (TLI), 30 the root mean square of approximation (RMSEA), 31 and the adjusted goodness-of-fit statistic (AGFI). 32 A non-significant chi square expresses adequate model fit. However, chi-square is sensible to sample-size. 33 The χ 2 /df ratio is a handy measure of fit, [34] [35] [36] with values smaller than 3 indicating good fit. 37 AGFI estimates the part of variance accounted for by the estimated population covariance; 38 values greater than 0.90 denote well-fitting models. The CFI and the TLI express the amount of variance and covariance accounted for by the model compared with an unstructured baseline model. These indexes are unaffected by sample size. 39, 40 Desirable CFI and TLI values are above 0.95, although values between 0.90 and 0.95 are acceptable. 29 The RMSEA describes fit per degrees of freedom of the model; values between 0.05 and 0.08 denote acceptable fit 39 and values lower than 0.05 express good fit. 41 Reliability was evaluated for each of the two dimensions using Cronbach's α. 42 Values≥0.7 suggest acceptable-to-high scale reliability.
Furthermore, in order to create the reduced form of the questionnaire, a Rasch model analysis was used to select the items with the best psychometric properties. 27, 43, 44 There is a long history of applications of Rasch models in the medical field. [45] [46] [47] [48] Given the specific measurement properties of Rasch models, they have been widely used for the development of brief measurement. [49] [50] [51] [52] [53] Rasch models characterize the responses of persons to items as a function of person and item measures. These measures pertain to the level of a quantitative latent trait possessed by a person or item, and their specific meaning relies on the subject of the assessment. In educational assessments, for instance, person measures indicate the ability of persons, and item measures indicate the difficulty of items. In health status assessments, person measures indicate the health of persons, and item measures indicate the severity of items. In the context of IDQs, providing a "true" answer to an item is analogous to stating the presence of the measured latent trait (ie, denial). The Rasch model is usually applied to evaluate psychometric tests since it is centered on the study of items and their properties. Items are ordered according to their severity (location or beta): items with less "true" responses are more severe, and items with more "true" responses are less severe. Severity is represented on a scale with mean zerothe higher the values, the higher the severity. Items should cover all the distinct levels of the trait of interest in order to properly measure it. Items covering the same level of the latent construct are redundant and can thus be dropped. An adequate coverage of the severity continuum suggests content representativeness and construct validity. 54 Fit indices show how well the data fit the model, and their technical quality is evaluated. Item fit addresses the extent to which an item is related to the rest of the scale. Unfitting items may be considered for elimination. A valid measurement tool should cover different levels of the trait continuum and should not contain items with differential item functioning 55 (DIF). In the presence of DIF, comparisons among groups are questionable: they should only be qualitative and not quantitative. 45 The absence of DIF items allows quantitative comparisons among scores of different groups to be made. 54 
Item reduction strategy
Given that unidimensionality is an assumption of the Rasch model, the two dimensions of denial were separately analyzed by fitting two Rasch models, one for "Denial of negative emotions" and the other for "Resistance to change." Given the equal distribution of items across the components, the same number of items was selected for each dimension. The length of the short form was not a priori defined but was suggested by statistical analyses. A minimum of 4 items per dimension was set in order not to weaken the scale too much. A two-step procedure was applied in order to create the short form: a) poorly functioning items were dropped; b) then, only the best items were selected for the short-form. First of all, DIF was analyzed to test the invariance of each item across different groups of subjects (patients and caregivers) and across sex (females and males). An item exhibiting DIF is differently answered by subjects with the same ability level but from different groups, and such nuisance factors affect goodness of measurement. 56 DIF results were considered in the selection of items since it is preferable to drop items showing DIF with large effect size 55 in order to obtain a test suitable for different subjects across sex and across groups (ie, patients and caregivers). Uniform and nonuniform DIF were considered: DIF is uniform if the item-group interaction is independent of the subjects' ability level, while DIF is nonuniform when the item functioning is related to the subjects' ability level. 57 Then, Rasch fit indices were used to evaluate item properties. Good fit indices mean that a certain item fits to the Rasch model's expectations based on item difficulties and subjects' ability level. Infit and outfit are sensitive to unexpected responses given a certain person's trait level.
Infit is more precise and detects unexpected responses to items that are close to a person's trait level, while outfit perceives "bigger" unexpected responses to items that are far from the subject's trait level. Fit indices rely on the mean square of the standardized residuals for items, which are not sample-size dependent. The expected value for fit indices is 1, but recommended values should not exceed 1.4 and might not be lower than 0.7. 58 Values above 1.4 suggest that there is unexplained variance (ie, underfit), while values lower than 0.7 mean that there is redundancy among the items (ie, overfit). Items showing outfit values over 1.4 were dropped, and items with fit indices closer to 1 were selected to be included in the short form.
Furthermore, the item severity (beta) was considered in order to select the items that allowed for covering the entire continuum, thus providing a well-graded tool assessing different levels of the measured dimension without redundant items. Finally, the clinical meaning of each item was critically discussed by expert clinicians and was then considered to wisely drive the item choice in order to assess all the relevant clinical areas.
All the data analyses were performed with R statistical environment (v. 3.5.0). 59 CFA was performed by using the "lavaan" package (v. 0.6.3), 60 while Rasch analyses were conducted with TAM (v. 2.12.18) 61 and "difR" (v. 5.0) 57 packages.
Results
Results from the CFA on the two dimensions of denial showed a two-factor structure with good fit indices. Despite the chi-square fit reaching statistically significant values [χ 2 =208.747; df=103; p<0.001], the other fit indices showed satisfying results. The CFI and the TLI values were above the desirable threshold, suggesting good fit (CFI=0.960; TLI=0.954). The RMSEA suggested acceptable fit [RMSEA=0.072 (90% CI from 0.058 to 0.086); p (RMSEA<0.05)=0.007]. The χ 2 /df ratio of the model 62 suggested the acceptability of the model (χ 2 /df=2.026; <3). 35 AGFI further suggested a well-fitting model (AGFI=0.911). As shown in Table 2 , all the items significantly loaded on the intended factor (p<0.001; mean loadings =0.662; SD loadings =0.154), ranging from 0.338 (Item12) to 0.928 (Item#6). Furthermore, a positive correlation between the two factors was found (r=0.619; p<0.001). In addition, both dimensions of denial showed good internal consistency (α=0.76 for "Denial of negative emotions"; α=0.72 for "Resistance to change").
Two Rasch models were separately fitted for the two dimensions of denial. Table 3 reports the parameters considered in the selection process. After fitting the Rasch model on the "Denial of negative emotions" items, in the first step of selection all critical items showing DIF were dropped: Item#2 and Item#17 showed DIF between patients and caregivers; Item#10 showed DIF across sex. In the second step, the remaining 4 items showed acceptable infit and outfit values: none exceeded 1.4 or was under the lower threshold. Those items well covered the latent trait continuum, and their clinical content was considered relevant and meaningful. Thus, the items for the short form were: Item#6, Item#7, Item#21, and Item#23. Given these results, the length for each scale was settled at 4 items. A second Rasch model was fitted on the "Resistance to change" items. In the first step of selection, no item showed DIF across sex, and only one item (Item#4) showed critical DIF across patients and caregivers and thus was dropped. In the second step, all the 8 remaining items showed satisfactory Rasch fit indices. Among them, the items with fit indices closer to the expected value of 1 were chosen. Also, the difficulty (beta parameter) and the clinical connotation were considered in the selection. Item#12 was chosen given its specific clinical meaning. The items in the couples Item#5-Item#13 and Item#11-Item#16 showed similar severity, but given the clinical meaning and the fit values, the items Item#5 and Item#16 were preferred. Finally, items Item#15 and Item#22 showed the same severity, but Item#22 was preferred given its clinical meaning. Thus, the other 4 items selected for the short form were Item#5, Item#12, Item#16, and Item#22.
The resulting IDQ-SF is a brief tool aimed at assessing illness denial. It is composed of 8 items, 4 from "Denial of negative emotions" (Item#6, Item#7, Item#21, Item#23) and 4 from "Resistance to change" (Item#5, Item#12, Item#16, Item#22).
Study 2
Study 2 was aimed at testing in a new sample the validity and the psychometric properties of the IDQ-SF developed in Study 1.
Materials and methods
Participants
This sample comprised 202 participants (58% females; mean age=55.93, SD=13.88). The inpatients group counted 113 subjects (47% females; for females: mean age=58.60, SD=13.00; for males: mean age=59, SD=12.93). The caregiver group was composed of 89 subjects (71.91% females; for females: mean age=52.02, SD=13.36; for males: mean age=52.88, SD=16.68). Caregivers showed different relationships with patients: 49 spouses/living-with (55.1%); 1 partner/not-living-with (1.1%); 4 parents (4.5%); 23 sons/daughters (25.8%); and 12 in another kind of relationship (13.5%). Patients and caregivers were enrolled from different medical wards: oncology (26.73%), neurology (24.26%), cardiology (23.27%), nephrology (16.34%), and pneumology (3.96%). Descriptive statistics are reported in Table 1 . After a short presentation made by a psychologist, all participants signed the informed consent allowing their data to be used in anonymous form. The study was discussed and approved by the ethical committee of the Maugeri Scientific Institute.
Instruments
Participants were presented with the IDQ-SFdeveloped in Study 1. They were asked to answer the 8 dichotomous items of the questionnaire with true or false according to their experience.
The Anxiety and Depression Questionnaire-Reduced Form (AD-R) was used for evaluating state anxiety and depression symptoms. 63 It is a reduction of the State-Trait Anxiety Inventory 64 and the Depression Questionnaire. 65 The anxiety subscale measures state anxiety with 10 items on a 4-level-rating scale (not at all=1, somewhat=2, moderately so=3, and very much so=4). The total score ranges between 0 and 40. The depression subscale measures depression symptoms with 15 dichotomous items (no=0; yes=1). The total score of this scale ranges from 0 to 15.
Statistical analyses
The factorial structure of IDQ-SF was studied via CFA. Given the results from Study 1 and from previous literature, 18 a two-factor structure was hypothesized. The DWLS was used as an estimator, and several indicators were considered to evaluate model fit: χ 2 , χ 2 /df, CFI, TLI, RMSEA, and AGFI. Internal consistency was evaluated using Cronbach's α. Concurrent validity was studied by correlating the IDQ-SF with the anxiety and depression subscales of the AD-R questionnaire.
Results
The CFA on the IDQ-SF tested the two-factor model where 4 items saturated in the factor "Denial of negative emotions" and 4 items saturated in the factor "Resistance to change." Fit indices showed that the two-factor structure of the IDQ-SF provided a good depiction of the item responses: χ 2 (19)=28.408; p=0.076. The χ 2 /df ratio of the model suggested the acceptability of the model (χ 2 /df=1.49; <3). Fit indices suggested ideal fit (CFI=0.987; TLI=0.981). The RMSEA further suggested 
2.
This disorder/disease has made me more insecure. (R) 0.566 0.320 Questo disturbo/malattia mi ha reso più insicuro.
6.
I am worried about this disorder/disease. (R) 0.928 0.861 Sono preoccupato per questo disturbo/malattia.
7.
This disorder/disease frightens me. (R) 0.855 0.731 Questo disturbo/malattia mi spaventa.
10.
Thinking about this disorder/disease leaves me quite indifferent. 0.641 0.410 Pensare a questo disturbo/malattia non mi fa "nè caldo nè freddo."
17.
This disorder/disease makes me feel angry. (R) 0.663 0.440 Sono arrabbiato a causa di questo disturbo/malattia.
21.
This disorder/disease makes me feel sad. (R) 0.834 0.695 Sono triste per questo disturbo/malattia.
23.
I am more irritable because of this disorder/disease. (R) 0.509 0.259 Sono più irritabile per questo disturbo/malattia.
Resistance to change
Item number
Item λ R 2
1.
There is no reason to modify my lifestyle on account of this disorder/disease. 0.498 0.248 Non c'è motivo di modificare abitudini a causa di questo disturbo/malattia.
4.
I am facing everything with serenity. 0.640 0.410 Sto affrontando tutto con serenità.
5.
I often think about how my life will be from now on. (R) 0.683 0.467 Penso spesso a come sarà la mia vita da adesso in poi.
11.
Some of my usual habits will have to change. (R) 0.669 0.448 Alcune mie abitudini dovranno cambiare.
12.
The treatments (medications, exercises, or others) do not in fact change my life. 0.338 0.114 Le terapie (farmaci, esercizi o altro) non cambiano affatto la mia vita.
13.
This disorder/disease is a heavy trial for me to bear. (R) 0.835 0.697 Questo disturbo/malattia mi mette a dura prova.
15.
I often think about how things are going to turn out. (R) 0.738 0.544 Penso a come andranno a finire le cose.
16.
Nothing in my life will change on account of this disorder/disease. 0.527 0.278 Niente nella mia vita cambierà a causa di questo disturbo/malattia.
22.
I will have to give up some of my usual habits. (R) 0.666 0.444 Dovrò abbandonare alcune abitudini.
Note: R=item reverse. Table 4 . Internal consistency was good for "Denial of negative emotions" (α=0.71) and for "Resistance to change" (α=0.58).
Concerning concurrent validity, correlations were calculated separately for patients and caregivers. The IDQ-SF total score showed a negative moderate correlation with anxiety subscales (patients=-0.57; caregivers=-0.45) and depression subscales (patients=-0.48; caregivers=-0.39). More information is provided in Table 5 .
General discussion
The present paper aimed at developing and validating a short form of the IDQ for patients and caregivers, considering the core dimensions of "Denial of negative emotions" and "Resistance to change." Study 1 was aimed at developing the short form. Results of this study confirmed the validity and reliability of the IDQ, as composed of these two related but different dimensions. According to hypotheses and in line with the previous study, results of CFA confirmed that these dimensions represent two factors concerning different aspects of the individual's life: one on the behavioral level and the other on the emotional level. Results of CFA were an introductory phase for the item reduction in which a Rasch model was independently fitted on the items of each of the two denial dimensions.
Rasch models represent valuable tools for the development and validation of brief assessment instruments. After considering the results of several statistics, Rasch analysis led to the selection of 4 items of "Denial of negative emotions" and 4 items of "Resistance to change," thus leading to the IDQ-SF, a reduced version consisting of 8 items that were invariant across patients and caregivers. Thanks to the Rasch model properties, the items of the IDQ-SF are presented on a growing level of denial, thus allowing clinicians to immediately visualize if denial is present and its severity. If Rasch had not been used, poorly functioning items could have been included in the short form.
Study 2 aimed at testing the validity of the short-form in a new sample: the factor structure of IDQ-SF was confirmed by a second CFA. The IDQ-SF also showed 
7.
This disorder/disease frightens me. 0.785 0.616 Questo disturbo/malattia mi spaventa.
21.
This disorder/disease makes me feel sad. 0.860 0.740 Sono triste per questo disturbo/malattia.
23.
I 18, 66 The IDQ-SF may have useful applications in the clinical field. By considering item severity, the answers of a subject can be evaluated to provide meaningful information to clinicians and health professionals. The number and the severity of endorsed items could indicate the psychological risk of a person and the urgency of clinical intervention.
This study is not free of limitations, and its results should be considered object of discussion by future studies. Our sample mainly involved patients affected by chronic diseases in the rehabilitation setting and their caregivers. Future research should consider acute phases of illness and post-rehabilitation conditions. [67] [68] [69] [70] An interesting future research topic would be to investigate the relationship among illness denial and other psychological conditions, such as well-being, stress, and caregivers' strain. Further studies are needed to extend or disconfirm our results and to deepen further aspects of the denial and illness elaboration process in order to improve the efficacy and quality of the offered clinical treatment.
Conclusion
Illness denial represents a critical issue in clinical practice, not always evenly defined and thus difficult to assess. In a previous study, denial was defined as a process in which one's perspective may fluctuate during the course of the illness before its acceptation.
The IDQ-SF represents a brief tool focusing on denial's core dimensions referring to the emotional experience and behavioral lifestyle change as previously emerged. Given its handy structure, the IDQ-SF's administration is fast, fitting for patients with low attention span, and also suitable for integration in longer assessment batteries or to monitor the individual's progress over time. Its interpretation and scoring are easier for clinicians, allowing an immediate depiction of the patient's/caregiver's intensity of denial, thus favoring the appropriate clinical intervention. In fact, psychological interventions need to promote the illness elaboration process, keeping in account that it fluctuates from denial to awareness to acceptance. The negative correlation among denial, anxiety, and depression 66 confirms that the individuals are not ready to cope with the illness in an effort to protect themselves from the perceived threat: this suggests a cautious approach by the clinicians in order to avoid even worse reactions and to help along the elaboration process of the illness.
Even if more studies are needed to deepen the role of denial in the illness elaboration process, the IDQ-SF may be a starting point for its assessment and in catalyzing the clinical and scientific discussion about this intriguing topic.
Abbreviations IDQ, Illness Denial Questionnaire; IDQ-SF, Illness Denial Questionnaire-Short Form; AD-R, Anxiety and Depression Questionnaire-Reduced Form; DIF, Differential Item Functioning.
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